{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T08:57:16Z","timestamp":1772355436592,"version":"3.50.1"},"reference-count":36,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2014,8,1]],"date-time":"2014-08-01T00:00:00Z","timestamp":1406851200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["medical-hypotheses.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Medical Hypotheses"],"published-print":{"date-parts":[[2014,8]]},"DOI":"10.1016\/j.mehy.2014.05.007","type":"journal-article","created":{"date-parts":[[2014,5,20]],"date-time":"2014-05-20T21:00:49Z","timestamp":1400619649000},"page":"148-150","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Aspirin may modify tumor microenvironment via antiplatelet effect"],"prefix":"10.1016","volume":"83","author":[{"given":"B.B.","family":"Su","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.H.","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Shi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Q.Q.","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Wan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"9826","key":"10.1016\/j.mehy.2014.05.007_b0005","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1016\/S0140-6736(12)60209-8","article-title":"Effect of daily aspirin on risk of cancer metastasis: a study of incident cancers during randomised controlled trials","volume":"379","author":"Rothwell","year":"2012","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.mehy.2014.05.007_b0010","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/S1734-1140(10)70262-0","article-title":"COX-2 as a target for cancer chemotherapy","volume":"62","author":"Ghosh","year":"2010","journal-title":"Pharmacol Rep"},{"issue":"5","key":"10.1016\/j.mehy.2014.05.007_b0015","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1172\/JCI111110","article-title":"Arachidonate metabolism in vascular disorders","volume":"72","author":"Majerus","year":"1983","journal-title":"J Clin Invest"},{"issue":"5","key":"10.1016\/j.mehy.2014.05.007_b0020","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1161\/01.RES.0000214553.37930.3e","article-title":"De novo synthesis of cyclooxygenase-1 counteracts the suppression of platelet thromboxane biosynthesis by aspirin","volume":"98","author":"Evangelista","year":"2006","journal-title":"Circ Res"},{"issue":"6","key":"10.1016\/j.mehy.2014.05.007_b0025","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1172\/JCI110576","article-title":"Selective cumulative inhibition of platelet thromboxane production by low-dose aspirin in healthy subjects","volume":"69","author":"Patrignani","year":"1982","journal-title":"J Clin Invest"},{"key":"10.1016\/j.mehy.2014.05.007_b0030","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/978-3-642-30331-9_3","article-title":"Mode of action of aspirin as a chemopreventive agent","volume":"191","author":"Dovizio","year":"2013","journal-title":"Recent Results Cancer Res"},{"issue":"1","key":"10.1016\/j.mehy.2014.05.007_b0035","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1111\/j.1365-2125.1980.tb04794.x","article-title":"Metabolism of salicylate during chronic aspirin therapy","volume":"9","author":"Rumble","year":"1980","journal-title":"Br J Clin Pharmacol"},{"issue":"5","key":"10.1016\/j.mehy.2014.05.007_b0040","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1038\/nrclinonc.2011.199","article-title":"The role of aspirin in cancer prevention","volume":"9","author":"Thun","year":"2012","journal-title":"Nat Rev Clin Oncol"},{"issue":"2","key":"10.1016\/j.mehy.2014.05.007_b0045","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1158\/1940-6207.CAPR-11-0391","article-title":"Aspirin in the chemoprevention of colorectal neoplasia: an overview","volume":"5","author":"Chan","year":"2012","journal-title":"Cancer Prev Res (Phila)"},{"issue":"16s","key":"10.1016\/j.mehy.2014.05.007_b0050","doi-asserted-by":"crossref","first-page":"3530","DOI":"10.1200\/jco.2005.23.16_suppl.3530","article-title":"Influence of regular aspirin use on survival for patients with stage III colon cancer: findings from Intergroup Trial CALGB 89803","volume":"23","author":"Fuchs","year":"2005","journal-title":"J Clin Oncol"},{"issue":"9","key":"10.1016\/j.mehy.2014.05.007_b0055","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1038\/bjc.2012.427","article-title":"Aspirin and other non-steroidal anti-inflammatory drug use and colorectal cancer survival: a cohort study","volume":"107","author":"Walker","year":"2012","journal-title":"Br J Cancer"},{"issue":"16","key":"10.1016\/j.mehy.2014.05.007_b0060","doi-asserted-by":"crossref","first-page":"4965","DOI":"10.1158\/0008-5472.CAN-13-0661","article-title":"Targeting the tumor microenvironment: from understanding pathways to effective clinical trials","volume":"73","author":"Fang","year":"2013","journal-title":"Cancer Res"},{"issue":"1","key":"10.1016\/j.mehy.2014.05.007_b0065","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1373\/clinchem.2012.185363","article-title":"Targeting the tumor microenvironment for cancer therapy","volume":"59","author":"Sounni","year":"2013","journal-title":"Clin Chem"},{"issue":"2","key":"10.1016\/j.mehy.2014.05.007_b0070","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1111\/j.1538-7836.2010.04131.x","article-title":"The platelet contribution to cancer progression","volume":"9","author":"Bambace","year":"2011","journal-title":"J Thromb Haemost"},{"issue":"5","key":"10.1016\/j.mehy.2014.05.007_b0075","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.ejim.2013.01.017","article-title":"The platelet-cancer loop","volume":"24","author":"Goubran","year":"2013","journal-title":"Eur J Intern Med"},{"issue":"25","key":"10.1016\/j.mehy.2014.05.007_b0080","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1038\/newbio231235a0","article-title":"Aspirin selectively inhibits prostaglandin production in human platelets","volume":"231","author":"Smith","year":"1971","journal-title":"Nat New Biol"},{"issue":"3","key":"10.1016\/j.mehy.2014.05.007_b0085","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1002\/ijc.2910110322","article-title":"Platelet\u2013tumor\u2013cell interactions in mice. The role of platelets in the spread of malignant disease","volume":"11","author":"Gasic","year":"1973","journal-title":"Int J Cancer"},{"issue":"12","key":"10.1016\/j.mehy.2014.05.007_b0090","doi-asserted-by":"crossref","first-page":"2747","DOI":"10.1002\/ijc.27441","article-title":"Tumor\u2013platelet interaction in solid tumors","volume":"130","author":"Buergy","year":"2012","journal-title":"Int J Cancer"},{"issue":"7","key":"10.1016\/j.mehy.2014.05.007_b0095","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1038\/sj.bjp.0706013","article-title":"Platelet\u2013cancer interactions: mechanisms and pharmacology of tumour cell-induced platelet aggregation","volume":"143","author":"Jurasz","year":"2004","journal-title":"Br J Pharmacol"},{"issue":"8","key":"10.1016\/j.mehy.2014.05.007_b0100","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1002\/jcp.24539","article-title":"Platelets in tumor progression: a host factor that offers multiple potential targets in the treatment of cancer","volume":"229","author":"Sharma","year":"2014","journal-title":"J Cell Physiol"},{"issue":"7","key":"10.1016\/j.mehy.2014.05.007_b0105","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1055\/s-2007-991540","article-title":"Inhibition of platelet function: does it offer a chance of better cancer progression control?","volume":"33","author":"Sierko","year":"2007","journal-title":"Semin Thromb Hemost"},{"issue":"6","key":"10.1016\/j.mehy.2014.05.007_b0110","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1139\/y2012-036","article-title":"Platelet-associated angiogenesis regulating factors: a pharmacological perspective","volume":"90","author":"Radziwon-Balicka","year":"2012","journal-title":"Can J Physiol Pharmacol"},{"issue":"9","key":"10.1016\/j.mehy.2014.05.007_b0115","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1038\/nm0901-987","article-title":"Normalizing tumor vasculature with anti-angiogenic therapy: a new paradigm for combination therapy","volume":"7","author":"Jain","year":"2001","journal-title":"Nat Med"},{"issue":"3","key":"10.1016\/j.mehy.2014.05.007_b0120","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.2353\/ajpath.2010.091021","article-title":"Hypoxia increases the expression of stem-cell markers and promotes clonogenicity in glioblastoma neurospheres","volume":"177","author":"Bar","year":"2010","journal-title":"Am J Pathol"},{"issue":"5706","key":"10.1016\/j.mehy.2014.05.007_b0125","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1126\/science.1104819","article-title":"Normalization of tumor vasculature: an emerging concept in antiangiogenic therapy","volume":"307","author":"Jain","year":"2005","journal-title":"Science"},{"issue":"5","key":"10.1016\/j.mehy.2014.05.007_b0130","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1111\/cts.12070","article-title":"Initiation of aspirin therapy modulates angiogenic protein levels in women with breast cancer receiving tamoxifen therapy","volume":"6","author":"Holmes","year":"2013","journal-title":"Clin Transl Sci"},{"key":"10.1016\/j.mehy.2014.05.007_b0135","doi-asserted-by":"crossref","DOI":"10.1016\/j.placenta.2013.12.006","article-title":"Review: novel insights into the regulation of vascular tone by sphingosine 1-phosphate","volume":"35","author":"Kerage","year":"2014","journal-title":"Placenta"},{"issue":"19","key":"10.1016\/j.mehy.2014.05.007_b0140","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1186\/1423-0127-19-102","article-title":"Hypoxia-regulated target genes implicated in tumor metastasis","volume":"14","author":"Tsai","year":"2012","journal-title":"J Biomed Sci"},{"issue":"1","key":"10.1016\/j.mehy.2014.05.007_b0145","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1161\/hh1301.092678","article-title":"Thrombin activates the hypoxia-inducible factor-1 signaling pathway in vascular smooth muscle cells: role of the p22(phox)-containing NADPH oxidase","volume":"89","author":"G\u00f6rlach","year":"2001","journal-title":"Circ Res"},{"issue":"15","key":"10.1016\/j.mehy.2014.05.007_b0150","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1161\/01.CIR.0000031332.45480.79","article-title":"Angiogenesis by implantation of peripheral blood mononuclear cells and platelets into ischemic limbs","volume":"106","author":"Iba","year":"2002","journal-title":"Circulation"},{"issue":"22","key":"10.1016\/j.mehy.2014.05.007_b0155","doi-asserted-by":"crossref","first-page":"7021","DOI":"10.1158\/0008-5472.CAN-11-1693","article-title":"Tumor-surrogate blood vessel subtypes exhibit differential susceptibility to anti-VEGF therapy","volume":"71","author":"Sitohy","year":"2011","journal-title":"Cancer Res"},{"issue":"1","key":"10.1016\/j.mehy.2014.05.007_b0160","doi-asserted-by":"crossref","first-page":"35","DOI":"10.6061\/clinics\/2012(01)06","article-title":"Regulation of hypoxia-inducible factor-1\u03b1 (HIF-1\u03b1) expression by interleukin-1\u03b2 (IL-1\u03b2), insulin-like growth factors I (IGF-I) and II (IGF-II) in human osteoarthritic chondrocytes","volume":"67","author":"Sartori-Cintra","year":"2012","journal-title":"Clinics (Sao Paulo)"},{"issue":"1","key":"10.1016\/j.mehy.2014.05.007_b0165","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1042\/BSR20110027","article-title":"Anti-neoplastic action of aspirin against a T-cell lymphoma involves an alteration in the tumour microenvironment and regulation of tumour cell survival","volume":"32","author":"Kumar","year":"2012","journal-title":"Biosci Rep"},{"issue":"12","key":"10.1016\/j.mehy.2014.05.007_b0170","doi-asserted-by":"crossref","first-page":"2198","DOI":"10.1007\/s10620-006-9428-2","article-title":"Correlation of GLUT-1 overexpression, tumor size, and depth of invasion with18F-2-fluoro-2-deoxy-d-glucose uptake by positron emission tomography in colorectal cancer","volume":"51","author":"Gu","year":"2006","journal-title":"Dig Dis Sci"},{"issue":"2","key":"10.1016\/j.mehy.2014.05.007_b0175","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1038\/nrc3004","article-title":"Contribution of platelets to tumour metastasis","volume":"11","author":"Gay","year":"2011","journal-title":"Nat Rev Cancer"},{"issue":"9","key":"10.1016\/j.mehy.2014.05.007_b0180","doi-asserted-by":"crossref","first-page":"e25962","DOI":"10.4161\/onci.25962","article-title":"Enhancing immunotherapy using chemotherapy and radiation to modify the tumor microenvironment","volume":"2","author":"Kershaw","year":"2013","journal-title":"Oncoimmunology"}],"container-title":["Medical Hypotheses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306987714002114?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306987714002114?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,10]],"date-time":"2019-08-10T17:10:07Z","timestamp":1565457007000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0306987714002114"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,8]]},"references-count":36,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014,8]]}},"alternative-id":["S0306987714002114"],"URL":"https:\/\/doi.org\/10.1016\/j.mehy.2014.05.007","relation":{},"ISSN":["0306-9877"],"issn-type":[{"value":"0306-9877","type":"print"}],"subject":[],"published":{"date-parts":[[2014,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Aspirin may modify tumor microenvironment via antiplatelet effect","name":"articletitle","label":"Article Title"},{"value":"Medical Hypotheses","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mehy.2014.05.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}